FDA Inspection 1170922 — ATSF NE Office
The FDA completed an inspection of ATSF NE Office on May 4, 2022 in Kimberly, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 4, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Kimberly, WI (United States)